FIXX - Homology Medicines GAAP EPS of -$0.61 revenue of $0.35M August, 14 2023 05:07 PM Homology Medicines Inc. 2023-08-14 17:07:32 ET Homology Medicines press release ( NASDAQ: FIXX ): Q2 GAAP EPS of -$0.61. Revenue of $0.35M (-56.3% Y/Y). For further details see: Homology Medicines GAAP EPS of -$0.61, revenue of $0.35M